NCT04492319View on ClinicalTrials.gov

Addition of Neostigmine to Levobupivacaine

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

September 29, 2020

Primary Completion Date

November 23, 2023

Study Completion Date

December 20, 2023

Conditions
Spermatic Cord Block
Interventions
DRUG

Control Test

spermatic cord block by 19 ml Levobupivacaine 0.5% plus 1 ml 0.9 normal saline in each side

DRUG

Neostigmine

spermatic cord block by 19 ml Levobupivacaine 0.5% plus 1 ml neostigmine 500 μg in each side .

Trial Locations (1)

11451

Faculty of Medicine, Cairo University., Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04492319 - Addition of Neostigmine to Levobupivacaine | Biotech Hunter | Biotech Hunter